All
Publication
Book
Conference
Comment on: ‘‘Cannabidiol for COVID-19 Patients with Mild to Moderate Symptoms (CANDIDATE Study): A Randomized, Double-Blind, Placebo-Controlled Clinical Trial’’ by Crippa et al.
Comment on: Cannabis use among Danish patients with cancer: a cross‑sectional survey of sociodemographic traits, quality of life, and patient experiences
Enhancing Endocannabinoid Control of Stress with Cannabidiol
Commensal bacterial metabolites may strengthen the effect of anti-IL6 treatment for COVID-19
The gut-liver axis in chronic liver disease associated with severe COVID-19
Intestinal dysbiosis in celiac disease: Decreased butyrate production may facilitate the onset of the disease
Zinc deficits, mucositis, and mucosal macrophage perturbation: is there a relationship?
Comment on: Patient-reported outcomes in those consuming medical cannabis: a prospective longitudinal observational study in patients with chronic pain
A pilot safety, tolerability and pharmacokinetic study of an oro-buccal administered cannabidiol-dominant anti-inflammatory formulation in healthy individuals: a randomized placebo-controlled single-blinded study
Gut Dysbiosis and the Intestinal Microbiome: Streptococcus thermophilus a Key Probiotic for Reducing Uremia
Gut Microbiota Metabolites in NAFLD Pathogenesis and Therapeutic Implications
Modulation of Gut Microbiota for the Prevention and Treatment of COVID-19
Increased PD-L1 Expression May Be Associated With the Cytokine Storm and CD8+ T-Cell Exhaustion in Severe COVID-19.
Gut-brain axis in the neurological comorbidity of COVID-19
Effects of olives and their constituents on the expression of ulcerative colitis: a systematic review of randomised controlled trials
International Precision Medicine Conference 2021
Oral administration of dermatan sulphate reduces venous thrombus formation in vivo: potential use as a formulation for venous thromboembolism
Altered gut microbial metabolites could mediate the effects of risk factors in Covid-19
Letter to the Editor: Could Butyrate Be Incorporated With Farnesoid X Receptor Agonist Cilofexor to Enhance Primary Sclerosing Cholangitis Treatment?
Probiotics and synbiotics targeting the intestinal microbiome attenuate non-alcoholic fatty liver disease
Innovating Humanity - Opioids to Covid-19, Learnings and Health Needs for Our Future
Targeting the Intestinal Microbiota to Prevent Type 2 Diabetes and Enhance the Effect of Metformin on Glycaemia: A Randomised Controlled Pilot Study
Potentiating New Neurological Pain Drugs from Cannabis (CBD/THC)
An oro-buccal nanoparticle delivered cannabis medicine for pain management in cancer: A clinical trial in progress.
The gallbladder and vermiform appendix influence the assemblage of intestinal microorganisms
A Double-Blind Randomized Placebo-Controlled Study Assessing the Safety, Tolerability and Efficacy of a Herbal Medicine Containing Pycnogenol Combined with Papain and Aloe vera in the Prevention and Management of Pre-Diabetes
Butyrate in Inflammatory Bowel Disease Therapy
Mind body medicine: a tangible link between the gut and the brain
The Role of Butyrate in Attenuating Pathobiont-Induced Hyperinflammation
Mitochondria could be a potential key mediator linking the intestinal microbiota to depression
The 27th Annual World Congress, A4M
Activation of T-regulatory cells by a synbiotic may be important for its anti-inflammatory effect
Signalling molecules and epigenetic targeting in cancer immunotherapy - Comments on "Epigenetic modulation enhances immunotherapy for hepatocellular carcinoma"
Bile acids and butyrate in the effects of probiotics/synbiotics on nonalcoholic fatty liver disease
Comments on "Supplementation with Lactobacillus reuteri ATCC PTA 4659 in patients affected by acute uncomplicated diverticulitis: a randomized double-blind placebo controlled trial"
Comments on "Supplementation with Lactobacillus reuteri ATCC PTA 4659 in patients affected by acute uncomplicated diverticulitis: a randomized double-blind placebo controlled trial"
Potentiating new Neurological pain drugs from cannabis (CBD/THC)
A double-blind randomized placebo controlled study assessing safety, tolerability and efficacy of palmitoylethanolamide for symptoms of knee osteoarthritis
A double-blind randomized placebo controlled study assessing safety, tolerability and efficacy of palmitoylethanolamide for symptoms of knee osteoarthritis
Effects of Intestinal Microbial⁻Elaborated Butyrate on Oncogenic Signaling Pathways
Interaction of gut microbiota with dysregulation of bile acids in the pathogenesis of nonalcoholic fatty liver disease and potential therapeutic implications of probiotics
The vermiform appendix: an immunological organ sustaining a microbiome inoculum
The Plasma Bioavailability of Coenzyme Q10 Absorbed from the Gut and the Oral Mucosa
The Plasma Bioavailability of Coenzyme Q10 Absorbed from the Gut and the Oral Mucosa
The role of adjuvant probiotics to attenuate intestinal inflammatory responses due to cancer treatments
Adjunctive Treatments for the Prevention of Chemotherapy- and Radiotherapy-Induced Mucositis
Inflammation-Modulating Effect of Butyrate in the Prevention of Colon Cancer by Dietary Fiber
Indoxyl sulfate induces apoptosis and hypertrophy in human kidney proximal tubular cells
The Brain-Intestinal Mucosa-Appendix-Microbiome-Brain Loop
Understanding the Trial NanaBis™
Intestinal microbiome shifts, dysbiosis, inflammation and non-alcoholic fatty liver disease
Route and Type of Formulation Administered Influences the Absorption and Disposition of Vitamin B12 Levels in Serum
Nutraceuticals and Functional Foods
Adjuvant Probiotics and the Intestinal Microbiome: Enhancing vaccines and immunotherapy outcomes
Intestinal Microbiome and Cancer Treatments/ Gut health Panel.
The intestinal microbiome, chemotherapy and adjuvant treatments with probiotics.
Mitigating Chronic Diseases.
Prediabetes and Early Diagnosed T2DM: safety tolerability and pilot exploratory study preliminary results.
Ageratum conyzoides L. inhibits 5-alpha-reductase gene expression in human prostate cells and reduces symptoms of benign prostatic hypertrophy in otherwise healthy men in a double blind randomized placebo controlled clinical study
Cancer Treatments, the Intestinal Microbiome and Probiotics.
The development of a evidence-based probiotic formulation and its efficacy in obesity and type 2 diabetes
Use of complementary and alternative medicines in people with depression and central obesity: findings from a Tai Chi and Qigong study
Mitigating the symptoms of chronic diseases through the administration of probiotics.
Mood disorders cognition and the intestinal mucosa
Pilot Study: Urinary Indoxyl Sulphate As A Predictor Of Postoperative Kidney Function Following Radical Tumour Nephrectomy.
The Effect of a Standardized Ginger Extract on Chemotherapy-Induced Nausea-Related Quality of Life in Patients Undergoing Moderately or Highly Emetogenic Chemotherapy: A Double Blind, Randomized, Placebo Controlled Trial
The intestinal microbiome, metabolic diseases and probiotics
Probiotics, D-Lactic acidosis, oxidative stress and strain specificity
Perna canaliculus and the Intestinal Microbiome
Combination curcumin and vitamin E treatment attenuates diet-induced steatosis in Hfe-/- mice
A combination of probiotics and magnesium orotate attenuate depression in a small SSRI resistant cohort: an intestinal anti-inflammatory response is suggested
Herbal Medicines and Chemotherapy Induced Peripheral Neuropathy (CIPN): a Critical Literature Review
The Efficacy Of A Novel Probiotic On Glucose Metabolism: A Randomised Controlled Trial.
The effect of a novel probiotic on metabolic biomarkers in adults with prediabetes and recently diagnosed type 2 diabetes mellitus: study protocol for a randomized controlled trial
Modulating the Gut Micro-Environment in the Treatment of Intestinal Parasites.
Nephrotoxic effects of cis-diamminedichloroplatinium II (cisplatin) can be ameliorated using Coenzyme Q10 (CoQ10).
A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN)
Invitation to Chair session on Nanotechnologies for Drug Delivery Systems: Redefining the Curve - Sustainable Compound Delivery Through Nanoparticles.
Invitation to speak at Opening Ceremony and Keynote Forum session: The Microbiome - A Universe of Therapeutic Potential.
Lactobacillus acidophilus Restores Functionality in Uremic Macrophages: Plausible or Lacking Evidence?
Probiotics modify tight-junction proteins in an animal model of nonalcoholic fatty liver disease
Neonatal and Infant Development: Instruction from the Microbiota
Indoxyl sulphate and kidney disease: Causes, consequences and interventions
New Insights into potential prevention and management options for chemotherapy-induced peripheral neuropathy.
An evidence-based scale for the antecedents of depressive symptoms in Australian adults.
Testofen, a specialised Trigonella foenum-graecum seed extract reduces age-related symptoms of androgen decrease, increases testosterone levels and improves sexual function in healthy aging males in a double-blind randomised clinical study
Metabolic Disorders: Instruction by the Gut Microbiome
TGFβ isoforms and receptors mRNA expression in breast tumours: prognostic value and clinical implications
Metabolic Interactions in the Gastrointestinal Tract (GIT): Host, Commensal, Probiotics, and Bacteriophage Influences
Neonatal and Infant Development: Influence of Bacteria.
Gut Bacteria and Health…Probiotics and the Microbiome.
Reactive oxygen species and their lifelong regulation of the metabolome.
Scientific Application for Innovative Delivery Systems: Bacteria and Nanotechnology Platforms
Probiotics in Clinical Practice and ICU.
Inter–Kingdom communication: bacterial instruction of host gene expression.
A multi-strain probiotic preparation in a mouse model of a high fat diet / obesity induced liver steatosis,
Influence of a Specialized Trigonella foenum graecum Seed Extract (Libifem) on Testosterone, Estradiol and Sexual Function in Healthy Menstruating Women, a Randomised Placebo Controlled Study
Chemotherapy-induced peripheral neuropathy (CIPN) and vitamin B12 deficiency
S-adenosylmethionine (SAMe) and Magnesium Orotate as adjunctives to SSRIs in sub-optimal treatment response of depression in adults; a pilot study
High Fat Diet, Probiotics and Non-Alcoholic Fatty Liver Disease
Live Probiotic Cultures and the Gastrointestinal Tract – Improving More Than Just GI Health
High Fat Diet, Probiotics and Non–Alcoholic Fatty Liver Disease
Depression and the Gut Microbiome Influence of Probiotics and Nutraceuticals
Perna canaliculus (Green-Lipped Mussel): Bioactive Components and Therapeutic Evaluation for Chronic Health Conditions
Gastrointestinal Tract Commensal Bacteria and Probiotics: Influence on End-Organ Physiology.
The gastrointestinal tract microbiome, probiotics and mood
Probiotics for the Gastrointestinal Tract (GIT) Microbiome: The Evidence-Based Market Leader.
Live Probiotic Cultures and the Gastrointestinal Tract: Symbiotic Preservation of Tolerance Whilst Attenuating Pathogenicity
The overarching influence of the gut microbiome on end-organ function: the role of live probiotic cultures
Probiotics, the gastrointestinal tract microbiome and musculoskeletal diseases.
A Randomised Placebo-Controlled Clinical Trial Assessing The Efficacy And Safety Of Supplementation With B Vitamins To Reduce The Incidence Of Chemotherapy-Induced Peripheral Neuropathy [CIPN]
The Effect Of Microbiota-Based Interventions And Metformin In Metabolic And Inflammatory Biomarkers In Adults With Type 2 Diabetes Mellitus (T2DM).
Ginger–Mechanism Of Action In Chemotherapy Induced Nausea And Vomiting: A Review.
The gastrointestinal tract microbiome and the metabolism of herbal compounds such as trigonella foenum-graecum extract.
Endocellular Regulation of Free Radicals and Hydrogen Peroxide: Key Determinants of the Inflammatory Response
Liver function parameters, cholesterol, and phospholipid α-linoleic acid are associated with adipokine levels in overweight and obese adults
Can ginger ameliorate chemotherapy-induced nausea? Protocol of a randomized double blind, placebo-controlled trial
Probiotics, prebiotics and the gastrointestinal tract in health and disease
Antioxidants to Abrogate Free Radicals. New insights to challenge currently held beliefs
Is co-prescribing a multi-strain probiotic the simple solution for treating and preventing Proton Pump Inhibitor (PPIs) induced Clostridium difficile Associated Diarrhoea (CDAD) while maintaining evidence based pharmacotherapy?
The Gastrointestinal Microbiota and Multi-Strain Probiotic Therapy: In Children and Adolescent Obesity
The Gastrointestinal Microbiome and Musculoskeletal Diseases: A Beneficial Role for Probiotics and Prebiotics
From the Gastrointestinal Tract (GIT) to the Kidneys: Live Bacterial Cultures (Probiotics) Mediating Reductions of Uremic Toxin Levels via Free Radical Signaling
Effects of probiotics supplementation on gastrointestinal permeability, inflammation and exercise performance in the heat
Omega-3 fatty acids: A review of the effects on adiponectin and leptin and potential implications for obesity management
The Pharmacobiotic Potential of the Gastrointestinal Tract Micro-Biometabolome-Probiotic Connect: A Brief Commentary
The Importance of Translational Research in Complementary and Alternative Medicines (CAMs)
Gut Microbiota and Metabolic Syndrome: How a Multi-Strain Probiotic may Influence Biomarkers in Obese Adolescents.
The Role of Gut Microbiota in Non-Alcoholic Fatty Liver Disease: The Efficacy of a Multi-Strain Probiotic in Obese Adolescents.
A phase II randomised double–blind placebo–controlled clinical trial investigating the efficacy and safety of a herbal medicine preparation for the management of symptoms of benign prostatic hypertrophy.
B Vitamin Status In Cancer Patients Administered Chemotherapy.
Is Ginger Supplementation Effective In Ameliorating Chemotherapy-Induced Nausea And Vomiting?
Nutraceuticals and Chemotherapy Induced Peripheral Neuropathy (CIPN): A Systematic Review.
Uremia and Chronic Kidney Disease: The role of the gut microflora and therapies with pro- and prebiotics
Key
Related Articles
Related Product Groups
NanoCelle® Related Ingredients
CORPORATE OFFICES
11-13 LORD ST, BOTANY
BUILDING A, UNIT A5 – A6, BOTANY QUARTER
NSW, 2019, AUSTRALIA
11-13 LORD ST, BOTANY
BUILDING A, UNIT A5 – A6, BOTANY QUARTER
NSW, 2019, AUSTRALIA
Regional and International offices
OUR WEBSITES
www.medlab.co
www.medlab.co
CONTACT DETAILS
OFFICE HOURS: 8:30AM - 5PM EST
AUS: 1300 369 570
AUS: +61 2 8188 0311
USA: +1 947 771 8119
UK: +44 20 8138 0311
FAX: +61 2 9699 3347
Email: hello@medlab.co
OFFICE HOURS: 8:30AM - 5PM EST
AUS: 1300 369 570
AUS: +61 2 8188 0311
USA: +1 947 771 8119
UK: +44 20 8138 0311
FAX: +61 2 9699 3347
Email: hello@medlab.co